Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Siebert | M | 84 | 13 years | |
| V. Lawlis | M | 72 | 5 years | |
| Nancy E. Pecota | F | 64 | 10 years | |
| Howard D. Palefsky | M | - |
Collagen Corp.
| 19 years |
| Igor Gonda | M | 76 | 17 years | |
| Richard P. Thompson | M | 72 | 11 years | |
| David Kabakoff | M | 76 | 9 years | |
| Stephen W. Kaldor | M | 62 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 years |
| Nathaniel David | M | 56 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 4 years |
| Deno G. Bokas | M | 61 | 1 years | |
| Dennis Jeffery Grimes | M | 60 | 3 years | |
| Leonid Beigelman | M | 66 | 4 years | |
| William Hodder | M | - | 4 years | |
| Gregory Flesher | M | 54 | 4 years | |
| Mark R. Thompson | M | 71 | 1 years | |
| Daniel P. Maher | M | - | 5 years | |
| Peter D. Noymer | M | 57 | 7 years | |
| Leslie Tari | M | 57 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 years |
| Karen S. Wright | F | 69 | 2 years | |
| Jennifer D. Haldeman | F | 59 | 1 years | |
| Thomas Chesterman | M | 64 | 5 years | |
| Stephen Jaeger | M | 79 | 5 years | |
| William Halter | M | 63 | 4 years | |
| David J. Foster | M | 66 |
Collagen Corp.
| 5 years |
| John R. Daniels | M | 85 |
Collagen Corp.
| 23 years |
| Bobba Venkatadri | M | 79 | 3 years | |
| Stephen Farr | M | 65 | 11 years | |
| Timothy Patrick Lynch | M | 54 | 2 years | |
| Tom R. Hodgson | M | 82 | - | |
| Richard B. Love | M | 62 | 3 years | |
| Maximillian D. Fiore | M | 69 | 9 years | |
| Jonathan Rigby | M | 56 | 4 years | |
| Cynthia Y. Robinson | M | 65 | 3 years | |
| John J. Turanin | M | 66 | 9 years | |
| Michael Molkentin | M | 69 | 2 years | |
| Roger L. Hawley | M | 71 | 3 years | |
| Jun Yoon | M | 46 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 37 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Norman L. Halleen
- Personal Network
